Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Investment U (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Altria Takes On Its Biggest Challenges Yet

% of readers think this story is Fact. Add your two cents.


Note: Today’s Safety Net comes from Assistant Research Manager Andrew Hubbarth. Chief Income Strategist Marc Lichtenfeld is currently returning from the 2020 Private Wealth Seminar in Park City, Utah, where he livestreamed to Oxford Club Members about the best opportunities in today’s market.


The popularity of traditional cigarettes has been in decline for years, but Altria‘s (NYSE: MO) dividend continues to rise as the company diversifies into new vices.

The days of the Marlboro Man and product placement in “cool” movie scenes are mostly gone – so Altria has shifted much of its attention to vaping and even marijuana.

But Altria still controls Philip Morris USA, and it makes a significant portion of its revenue from traditional tobacco products.

This revenue stream is reliable due to the difficulties of quitting tobacco – even in the face of higher tobacco taxes, strict advertising controls and younger demographics avoiding the substance.

And in 2018, Altria looked to pick up the slack from some of these challenges with a massive $12.8 billion (35%) investment in electronic cigarette manufacturer Juul Labs.

This deal has been controversial from the start because of monopoly concerns. This past April, the Federal Trade Commission even filed an antitrust lawsuit against Altria.

It will take time to resolve, but in January, Altria took a $4.1 billion write-down of its Juul investment due to the increasing number of lawsuits it faced.

Some of the lawsuits focused on vaping-related lung illnesses, and some contended that young people have been targeted by deceptive marketing.

Also in 2018, Altria bought 45% of Canadian marijuana company Cronos Group (Nasdaq: CRON) for $1.8 billion.

This investment has yet to be profitable, as the overall cannabis industry has declined after a much-hyped beginning just a few years ago.

Do these hurdles mean Altria’s dividend is in trouble?

Altria has raised its dividend each year since its last cut in 2008, and its dividend has grown 10% over the last five years.

This earns a positive mark in the SafetyNet Pro grading system.

What Is SafetyNet Pro?

SafetyNet Pro is a groundbreaking tool that predicts dividend cuts with stunning accuracy. With it, you can determine the dividend safety rating of nearly 1,000 stocks. Access to SafetyNet Pro is reserved exclusively for subscribers of Marc’s newsletter, The Oxford Income Letter. To learn more about SafetyNet Pro and The Oxford Income Letter, click here now.

Altria’s current quarterly dividend is $0.84.Like many companies facing uncertainties due to the coronavirus pandemic, Altria withdrew its 2020 profit forecasts.

However, management reiterated that the dividend “is a top priority.” It also stated that it is targeting an 80% payout ratio.

That’s good news because Altria’s 2020 payout ratio is currently forecast at 77% and set to hold steady in 2021.

Altria said the impact of the pandemic was “not material” to its business because most of its products are sold in convenience stores and other places deemed essential.

Still, there are concerns that downgrades to cheaper products will decrease profit margins.

Altria also borrowed the full $3 billion available through its credit revolver, which provides a cash cushion but also signals uncertainty even when a company is publicly confident.

And yet, despite the company’s legal uncertainties, pandemic concerns and questionable diversification efforts, its free cash flow forecast looks comforting.

Altria should continue to provide a safe return.

Dividend Safety Rating: C

If you have a stock whose dividend safety you’d like to see analyzed, leave the ticker symbol in the comments section.

Good investing,

Andrew

The post Altria Takes On Its Biggest Challenges Yet appeared first on Investment U.

Founded in 1999, the goal of Investment U is to give you impartial, no-nonsense investment advice and investment research on how to build long-lasting wealth.


Source: https://investmentu.com/altria-mo-dividend-safety/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login